Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Daniel Kruse Insider Profile
4 Followers
Daniel Kruse, Managing Director at SynBiotic SE, holds ― shares in SynBiotic SE (Ticker: DE:SBX). Most recently, Daniel Kruse Bought €6,600 shares of SynBiotic SE on Nov 28, 2023 for an estimated value of 20.09K.
Daniel Kruse has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Daniel Kruse does not currently own shares as a corporate insider.
A breakdown of Daniel Kruse's holdings
Insider Roles
Managing Director
Roles that Daniel Kruse holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Daniel Kruse
Daniel Kruse's Trading History
List of latest transactions for each holding click on a transaction to see Daniel Kruse's performance on stock
You May Also Like
Daniel Kruse insider profile FAQ
What is the percentage of profitable transactions made by Daniel Kruse?
The percentage of profitable transactions made by Daniel Kruse is ―.
What is the average return per transaction made by Daniel Kruse?
The average return per transaction made by Daniel Kruse is ―.
What stocks does Daniel Kruse hold?
Daniel Kruse holds: DE:SBX stocks.
What was Daniel Kruse’s latest transaction?
Daniel Kruse latest transaction was an Informative Buy of €20.09K.
What was Daniel Kruse's most profitable transaction?
Daniel Kruse’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Daniel Kruse's role in SynBiotic SE?
Daniel Kruse's role in SynBiotic SE is Managing Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.